No Data
Medidata and Tigermed Renew Strategic Partnership Aimed at Accelerating Clinical Trials Globally
TIGERMED (03347) spent 4.1285 million yuan on January 23 to repurchase 0.0849 million shares of A-shares.
TIGERMED (03347) announced that on January 23, 2025, it will invest 4.1285 million yuan (RMB...
TIGERMED (03347.HK) spent 3.26 million Hong Kong dollars on January 22 to repurchase 0.067 million shares.
Gelonghui reported on January 22 that TIGERMED (03347.HK) announced the repurchase of 0.067 million shares at a cost of 3.26 million Hong Kong dollars on January 22.
Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Not Lagging Market On Growth Or Pricing
China Securities Co.,Ltd.: An outlook on the pharmaceutical Industry 2024 annual report.
In 2025, the Industry is expected to achieve moderate growth and overall move towards high-quality development.
This week, an additional 29 companies have announced! TIGERMED and several other stocks disclosed repurchase and shareholding refinancing plans, with a list of related A-shares overview.
① The number of A-share listed companies receiving special loan support continues to expand. According to incomplete Statistics, as of the time of writing, 29 listed companies have disclosed information related to share repurchase and increased shareholding for re-loan this week (see attached table); ② TIGERMED received the highest amount of special loan support, totaling no more than 0.7 billion yuan.
